Publication

Research Article

Q3 | Volume 27

Unspoken Challenges: Sexual Health in Sexual and Gender Minority People With Multiple Sclerosis

CE Information

Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare.

Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, rehabilitation professionals, mental health professionals, social workers, and other health care providers involved in the treatment of patients with multiple sclerosis (MS).

Learning Objectives:

  1. Identify sexual health disparities in sexual and gender minority individuals with MS and recognize how these affect clinical care.
  2. Apply inclusive sexual history-taking techniques and incorporate affirming, individualized strategies to manage sexual dysfunction and reproductive health concerns in this population.

Accreditation: In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Intellisphere, LLC. The CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education, the Accreditation Council for Pharmacy Education, and the American Nurses Credentialing Center, to provide continuing education for the health care team.

This activity was planned by and for the health care team, and learners will receive .5 Interprofessional Continuing Education credit for learning and change.

Physicians: The CMSC designates this journal-based activity for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: The CMSC designates this enduring material for .5 contact hour of nursing continuing professional development (none in the area of pharmacology).

Psychologists: This activity is awarded .5 CE credits.

Social Workers: As a jointly accredited organization, the CMSC is approved to offer social work continuing education by the Association of Social Work Boards Approved Continuing Education program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive .5 general continuing education credits.

Disclosures: It is the policy of the CMSC to mitigate all relevant financial disclosures from planners, faculty, and other persons that can affect the content of this CE activity. For this activity, all relevant disclosures have been mitigated.

Disclosures: Francois Bethoux, MD, editor in chief of the International Journal of MS Care (IJMSC), has served as physician planner for this activity. He has disclosed no relevant financial relationships. Alissa Mary Willis, MD, associate editor of IJMSC, has disclosed no relevant financial relationships. Authors Alexandra Balshi, BS; Maya Behn, MD; and Tamara B. Kaplan, MD, have disclosed no relevant financial relationships.

The staff at IJMSC, CMSC, and Intellisphere, LLC, who are in a position to influence content have disclosed no relevant financial relationships. Laurie Scudder, DNP, NP, CMSC continuing education director, has served as a planner and reviewer for this activity. She has disclosed no relevant financial relationships.

Method of Participation:

Release date: August 25, 2025; Valid for credit through: September 1, 2027.

To receive CE credit, participants must:

  1. Review the continuing education information, including learning objectives and author disclosures.
  2. Study the educational content.
  3. Complete the evaluation, which is available at https://www. highmarksce.com/mscare.

Statements of Credit are awarded upon successful completion of the evaluation. There is no fee to participate in this activity.

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. The CMSC and Intellisphere do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the CMSC or Intellisphere.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

Abstract

Sexual health is an integral part of overall well-being, encompassing emotional, psychological, and physical aspects that profoundly influence quality of life. Despite the prevalence of sexual dysfunction (SD) among people with multiple sclerosis (MS), it is too frequently underreported and undertreated. Sexual and gender minority (SGM) people with MS, in particular, may face stigma, discrimination, and clinician hesitancy that can bar access to necessary sexual health care. Recognizing SGM identity can help clinicians deliver more inclusive general and sexual health care, including but not limited to family planning and gender-affirming care. The 8 Ps model can aid in taking a nonjudgmental sexual history that allows for recognition of sexual dysfunction regardless of identity.

From Harvard Medical School, Boston, MA (AB, MB, TBK); Lucile Packard Children’s Hospital, Stanford Medicine, Palo Alto, CA (MB); and the Department of Neurology, Mass General Brigham, Boston, MA (TBK). Correspondence: Tamara B. Kaplan, MD, Mass General Brigham, 60 Fenwood Road, Boston MA, 02115; email: tbkaplan@bwh.harvard.edu.

Practice Points
  • Sexual health is a vital aspect of well-being, profoundly influencing emotional, psychological, and physical quality of life for people with multiple sclerosis (MS), yet sexual dysfunction remains prevalent and often undertreated in this population.
  • Sexual and gender minority (SGM) individuals with MS face additional challenges, including stigma, discrimination, and health care disparities, which can limit access to sexual health services, including family planning and gender-affirming care.
  • Tools such as the 8 Ps model for inclusive sexual history-taking can help enhance care for SGM people with MS, ensuring conversations are comprehensive, respectful, and person-centered.

Addressing sexual health is fundamental to holistic care. The World Health Organization defines sexual health as a “state of physical, emotional, mental, and social well-being in relation to sexuality and not merely the absence of disease, dysfunction, or infirmity. Sexual health requires a positive and respectful approach to sexuality and sexual relationships, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, discrimination and violence. For sexual health to be attained and maintained, the sexual rights of all persons must be respected, protected and fulfilled.”1 As a vital part of emotional, psychological, and physical well-being, positive sexual health is associated with lower levels of depression and anxiety, higher quality of life, and greater life satisfaction in the general population.2

Sexual dysfunction (SD) is defined as persistent or recurrent problems with sexual response, desire, orgasm, or pain that cause significant distress or interpersonal difficulty. The major categories of sexual dysfunction include disorders of sexual desire/interest, arousal, orgasm, and sexual pain.3 Multiple sclerosis (MS) can lead to SD, with reduced libido and difficulties with sexual arousal, function, and satisfaction, all negatively impacting sexual health. Although the majority of people with MS experience sexual dysfunction,4,5 there is notably little literature surrounding the intersection of neurological conditions, sexual wellness, and sexual and gender minority (SGM) identity. In this review, we summarize existing research on these topics, identify unmet needs for SGM people with MS, and suggest future research and clinical practice.

MS and Sexual Health

SD is a prevalent concern in people with MS; meta-analyses estimate that approximately 64% experience it.4-7 Despite its high prevalence, SD is too often underreported, inadequately assessed, and undertreated in people with MS.5-9 Neglecting sexual dysfunction ignores a substantial concern for this population, as recent studies have revealed that SD contributes more to mental health and quality of life than neurological disability in people with MS.10

Although SD’s exact etiology in MS remains unclear, Foley et al proposed that it may manifest from primary, secondary, and tertiary causes.11,12 Primary SD refers to problems that result from direct damage to the nervous system as a result of cortex and spinal cord demyelination; this may include symptoms such as genital numbness, decreased lubrication, and erectile dysfunction. Secondary causes are neurological symptoms and physical disabilities that affect sexual function, such as fatigue, spasticity, pain, and bladder and bowel dysfunction. Finally, tertiary causes result from psychosocial stressors associated with having MS. The majority of people with MS report that primary, secondary, and tertiary factors all contribute to their SD.

Treating SD in people with MS involves multidisciplinary interventions that aim to address both physical and psychological components. Pharmacologic treatments such as phosphodiesterase inhibitors for erectile dysfunction and topical estrogen for vaginal dryness in postmenopausal women can help manage physical symptoms.13,14 Psychotherapy has been shown to be effective in addressing emotional and relational challenges associated with SD, helping people with MS and their partners communicate effectively and rebuild intimacy.15-17 Additionally, physical therapy, including pelvic floor exercises,18,19 can improve muscle strength and control, thereby improving sexual function. Aquatic exercise20 has also been proven to improve self-reported sexual desire, arousal, lubrication, orgasm, satisfaction, and pain, while yoga21 was associated with improved sexual satisfaction; both can be offered if people with MS seek nonpharmacologic or nontherapy strategies to address SD. This holistic approach to SD addresses the sexual health of people with MS by treating its primary, secondary, and tertiary causes.

SGM Populations

Discussing sexual health necessitates an overview of SGM people, which is a group that is underrepresented when discussing approaches to SD in people with MS.

The SGM population includes individuals whose sexual identity, gender identity, or reproductive development differs from conventional societal, cultural, or physiological norms.22 SGM individuals represent approximately 7% of the global population,23 which is likely an underestimate due to past and present criminalization of and discrimination against this population in many parts of the world. Likewise, health care barriers in SGM populations are well-documented and include disparities in access to care, discrimination, and inadequate cultural competence among health care professionals, with transgender individuals facing the greatest inequities.24-26 These SGM health care disparities can create a climate of reluctance to disclose sexual histories and problems in health care settings. A systematic review of many SGM individuals revealed that fear of unequal care, potential negative personal reactions from health care professionals, breaches in patient-clinician confidentiality, and documentation of SGM identity in medical records were all reasons for not disclosing their SGM identity in a health care setting.27

Recent research indicates that those in the sexual minority may be more susceptible to SD compared with their heterosexual counterparts.28 This disparity is attributed to multiple factors, including higher rates of mental health issues within SGM populations29 and difficulties arising from societal perceptions of their relationships,30 both of which can negatively impact sexual satisfaction and functioning. Additionally, limited access to LGBTQ+ inclusive clinicians further restricts access to essential sexual health services.

Intersectionality of MS, Sexual Health, and SGM Identity

In the context of MS care, comfort with SGM identity disclosure and perceived discrimination remain concerns. A survey of Italian people with MS demonstrated that sexual minority individuals were more likely to switch MS centers compared with their heterosexual counterparts, with 85.7% reporting at least 1 experience of homophobic behavior from clinical staff.31 More recently, a survey of 285 people with MS who self-identified as SGM documented less comfort discussing sexual health with their clinician and less satisfaction with their clinician overall compared with heterosexuals.32 Similarly, Anderson et al found that 30% of SGM individuals with MS felt uncomfortable discussing their SGM identities with their clinician. Additionally, this group reported lower mean satisfaction scores in the domain of sexual health relative to other health domains.33

Clinicians’ understanding of the SGM identities of people with MS is essential for bettering sexual and reproductive health. For example, all people with MS with gestational capacity must be made aware of disease-modifying therapy indications and timing surrounding pregnancy to ensure safe and informed family planning decisions. Considering that SGM individuals are often less likely to receive reproductive counseling,34 clinicians should proactively and nonjudgmentally inquire about reproductive goals to ensure safe pregnancy outcomes. However, a recent survey of American Academy of Neurology members’ preparedness to treat SGM individuals reported that one-third of those polled would not tailor neurologic care based on SGM identity, and 43% believed that sexual or gender identity has no bearing on the management of neurologic illness.35 Further, a scoping review of all SGM research in the field of neurology revealed that a mere 1.7% of SGM papers focus on MS.36 The paucity of literature concerning SGM people with MS could be contributing to neurologists’ decreased attention to the unique health care needs of this population, further exacerbating health care disparities for the SGM population.

Interventions

Effective interventions are essential to overcoming barriers in SGM health. Two common reasons clinicians hesitate to take a sexual history are concern about making patients feel uncomfortable or feeling uncomfortable themselves. In an emergency department study, nearly 80% of clinicians believed patients would refuse to disclose their sexual and gender identity. However, only 10% of patients studied (including heterosexual individuals) stated they would withhold this information.37 Thus, if a clinician feels that inquiring about SGM identity is appropriate, they should feel confident in doing so, especially if done in a respectful and affirming manner.

The process of taking a sexual history is often thought of as a means of assessing risk for sexually transmitted infections and/or pregnancy. However, the conversation presents a meaningful opportunity to discuss multiple aspects of care for people with MS. In addition to considerations such as contraception or pregnancy planning for individuals with reproductive capacity, MS itself can lead to sexual problems, and many of the medications used to manage MS symptoms may further contribute to these issues (eg, baclofen and selective serotonin reuptake inhibitors are associated with SD), impacting quality of life.38 Proactively addressing the potential sexual adverse effects of medications can prevent frustration and help individuals make informed decisions about treatment options. For example, sexual issues are often treatable with changes in drug dosing time, amount, or duration, or additional therapies to increase function. Even if someone is not experiencing difficulties, having transparent, open-ended conversations can help put them at ease and will help them raise questions with their health care providers if the need arises.

Fenway Health, a Boston, Massachusetts–based clinic focusing on SMG health care, created the 8 Ps model for taking a comprehensive sexual history based on best-practice guidelines from the Centers for Disease Control, but modified to be more inclusive (Table 1).39 For SGM people with MS, we pay particular attention to pregnancy, pleasure, and partner abuse. As discussed previously, family planning should be discussed with all people with reproductive capacity. It is also important to clarify preferences and vocabulary so that counseling can be informative and affirming. People with chronic diseases40 and SGM individuals41 are less likely than their healthy, cisgender, heterosexual peers to receive contraceptive counseling, highlighting the need for health care professionals to initiate these conversations to ensure inclusive, person-centered care and address potential disparities in reproductive health.

Table 1. The 8Ps Model for Taking a Comprehensive Sexual History (Adapted From Fenway Health 39)

Table 1. The 8Ps Model for Taking a Comprehensive Sexual History (Adapted From Fenway Health39)

A survey of people with MS at a large, academic hospital found that more than one-third of women with MS had experienced abuse in their lives, consistent with the general population, and 15% had experienced abuse in the past year. Higher levels of neurologic disability were associated with increased experience of abuse.42 Poor mental health, cognitive challenges, and difficulty managing disease all contribute to increased vulnerability.43 SGM individuals are also at higher risk for experiencing abuse.44 Bisexual women are 1.8 times more likely to report experiences of intimate partner violence (IPV)—physical, sexual, emotional, or psychological harm caused by a current or former partner—and 2.6 times more likely to report sexual violence than heterosexual women. The lifetime prevalence of IPV among transgender people has been reported to range from 31% to 50%.44 Given these statistics, it is crucial for clinicians to routinely ask about abuse in SGM people with MS and to involve social work services to provide appropriate support and interventions if indicated.

Discussion

Sexual health significantly contributes to overall well-being, as sexual wellness is associated with decreased depression and anxiety and greater life satisfaction.2 Despite affecting the majority of people with MS,45 SD remains too frequently underreported and thus undertreated.4-8 SGM people with MS face disproportionate sexual health disparities; they are less comfortable discussing their sexual health with their clinicians and also report decreased satisfaction when doing so compared with heterosexual people with MS. Unfortunately, many experience homophobic behavior, prompting them to switch MS centers as a result.31-33 Many neurologists may still overlook the significance of SGM identity when managing MS.35 Taken together, these barriers bar open patient-clinician communication, ultimately leaving SGM people with MS without the necessary support and interventions to treat SD effectively.

Neurologists can turn to adolescent oncology care for an example of where SGM health is prioritized. The National Comprehensive Cancer Network has published guidelines that emphasize the importance of creating an inclusive, safe, and comfortable space for SGM patients, writing that “integral to the comprehensive care of individuals with cancer…is an assessment for gender expression, gender identity, pronouns, and sexual identity.” These guidelines recommend involving SGM support persons identified by SGM patients, initiating referrals for psychosocial support, and considering referrals to specialized gender clinics for transgender youth.46

Integrating SGM-affirming approaches into neurological care can enhance patient-clinician communication and trust, ultimately improving sexual health and overall well-being for this population. Implementing inclusive sexual history-taking methods, such as the 8 Ps, can open the door to discussing SD and family planning regardless of sexual and gender identity.39 Given the heightened vulnerability of both SGM individuals and people with MS to IPV, routine screening for this is critical and is part of the 8 Ps.39,41,43 Beyond the neurologic visit, interdisciplinary care can help address sexual health concerns, facilitate inclusive discussions, and ensure comprehensive care for SGM people with MS. Given the increasing demands on physicians and limited visit times, referrals to psychologists, social workers, and physical therapists can enhance sexual health care for SGM people with MS. These interventions are summarized in Table 2.

Table 2. Actionable Ways to Improve Sexual Health Care for Sexual and Gender Minority People With Multiple Sclerosis

Table 2. Actionable Ways to Improve Sexual Health Care for Sexual and Gender Minority People With Multiple Sclerosis

Conclusions

Beyond making the clinical space more inclusive, adequately treating SD and improving sexual health in SGM people with MS requires more research, as our review of the literature identified several gaps in evidence surrounding this population. We did not identify any SD treatment trials that made note of sexual orientation, let alone any with a focus on SGM people with MS. Future SD treatment trials in people with MS should aim to include SGM individuals, and further qualitative studies surrounding their barriers to sexual health care and specific sexual health needs are essential. Research surrounding gender-affirming hormone therapy, especially as it relates to sexual health, in people with MS is also lacking and would greatly enhance care for this population.

Conflicts of Interest: The authors have declared no relevant conflicts of interest.

Funding: The work of Tamara B. Kaplan, MD, in this area is generously supported by the Beker Foundation.

References

  1. World Health Organization. Sexual health. Accessed February 12, 2025. https://www.who.int/health-topics/sexual-health#tab=tab_2

  2. Vasconcelos P, Carrito ML, Quinta-Gomes AL, et al. Associations between sexual health and well-being: a systematic review. Bull World Health Organ. 2024;102(12):873-887D. doi:10.2471/BLT.24.291565

  3. Hatzimouratidis K, Hatzichristou D. Sexual dysfunctions: classifications and definitions. J Sex Med. 2007;4(1):241-250. doi:10.1111/j.1743-6109.2007.00409.x

  4. Salari N, Hasheminezhad R, Abdolmaleki A, et al. The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis. Neurol Sci. 2023;44(1):59-66. doi:10.1007/s10072-022-06406-z

  5. Dastoorpoor M, Zamanian M, Moradzadeh R, Nabavi SM, Kousari R. Prevalence of sexual dysfunction in men with multiple sclerosis: a systematic review and
    meta-analysis. Syst Rev. 2021;10(1):10. doi:10.1186/s13643-020-01560-x

  6. Gromisch ES, Schairer LC, Pasternak E, Kim SH, Foley FW. Assessment and treatment of psychiatric distress, sexual dysfunction, sleep disturbances, and pain in multiple sclerosis: a survey of members of the Consortium of Multiple Sclerosis Centers. Int J MS Care. 2016;18(6):291-297. doi:10.7224/1537-2073.2016-007

  7. Domingo S, Kinzy T, Thompson N, Gales S, Stone L, Sullivan A. Factors associated with sexual dysfunction in individuals with multiple sclerosis: implications for assessment and treatment. Int J MS Care. 2018;20(4):191-197. doi:10.7224/1537-2073.2017-059

  8. Wang G, Marrie RA, Fox RJ, et al. Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis. Mult Scler Relat Disord. 2018;20:16-21. doi:10.1016/j.msard.2017.12.006

  9. Tudor KI, Eames S, Haslam C, Chataway J, Liechti MD, Panicker JN. Identifying barriers to help-seeking for sexual dysfunction in multiple sclerosis. J Neurol. 2018;265(12):2789-2802. doi:10.1007/s00415-018-9064-8

  10. Schairer LC, Foley FW, Zemon V, et al. The impact of sexual dysfunction on
    health-related quality of life in people with multiple sclerosis. Mult Scler. 2014;20(5):610-616. doi:10.1177/1352458513503598

  11. Foley FW, Sanders A. Sexuality, multiple sclerosis and women. MS Management. 1997;4(1):3-10.

  12. Foley FW, Zemon V, Campagnolo D, et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample. Mult Scler. 2013;19(9):1197-1203. doi:10.1177/1352458512471876

  13. Francomano D, Ilacqua A, Cortese A, et al. Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study. J Endocrinol Invest. 2017;40(3):275-279. doi:10.1007
    /s40618-016-0557-y

  14. Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ, Sweeney M. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005;76(5):700-705. doi:10.1136/jnnp.2004.038695

  15. Blackmore DE, Hart SL, Albiani JJ, Mohr DC. Improvements in partner support predict sexual satisfaction among individuals with multiple sclerosis. Rehabil Psychol. 2011;56(2):117-122. doi:10.1037/a0023362

  16. Foley FW, LaRocca NG, Sanders AS, Zemon V. Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis. Mult Scler. 2001;7(6):417-421. doi:10.1177/135245850100700612

  17. Bronner G, Elran E, Golomb J, Korczyn AD. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol Scand. 2010;121(5):289-301. doi:10.1111/j.1600-0404.2009.01314.x

  18. Altunan B, Gundogdu AA, Ozcaglayan TIK, Unal A, Turgut N. The effect of pelvic floor exercise program on incontinence and sexual dysfunction in multiple sclerosis patients. Int Urol Nephrol. 2021;53(6):1059-1065. doi:10.1007/s11255-021-02804-y

  19. Lúcio AC, D’Ancona CA, Lopes MH, Perissinotto MC, Damasceno BP. The effect of pelvic floor muscle training alone or in combination with electrostimulation in the treatment of sexual dysfunction in women with multiple sclerosis. Mult Scler. 2014;20(13):1761-1768. doi:10.1177/1352458514531520

  20. Sadeghi Bahmani D, Motl RW, Razazian N, Khazaie H, Brand S. Aquatic exercising may improve sexual function in females with multiple sclerosis - an exploratory study. Mult SclerRelat Disord. 2020;43:102106. doi:10.1016/j.msard.2020.102106

  21. Najafidoulatabad S, Mohebbi Z, Nooryan K. Yoga effects on physical activity and sexual satisfaction among the Iranian women with multiple sclerosis: a randomized controlled trial. Afr J Tradit Complement Altern Med. 2014;23(11 5):78-82. doi:10.4314/ajtcam.v11i5.13

  22. Sexual and Gender Minority Research Office. Sexual and gender minority populations in NIH-supported research. National Institutes of Health. August 28, 2019. Accessed July 31, 2025. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-139.htm

  23. Ipsos. LGBT+ Pride 2021 Global Survey. Accessed July 31, 2025. https://www.ipsos.com/sites/default/files/ct/news/documents/2021-06/LGBT%20Pride%202021%20Global%20Survey%20Report_6.pdf

  24. Cahill S, Makadon H. Sexual orientation and gender identity data collection in clinical settings and in electronic health records: a key to ending LGBT health disparities. LGBT Health. 2014;1(1):34-41. doi:10.1089/lgbt.2013.0001

  25. Yarns BC, Abrams JM, Meeks TW, Sewell DD. The mental health of older LGBT adults. Curr Psychiatry Rep. 2016;18(6):60. doi:10.1007/s11920-016-0697-y

  26. Winter S, Diamond M, Green J, et al. Transgender people: health at the margins of society. Lancet. 2016;388(10042):390-400. doi:10.1016/S0140-6736(16)00683-8

  27. Brooks H, Llewellyn CD, Nadarzynski T, et al. Sexual orientation disclosure in health care: a systematic review. Br J Gen Pract. 2018;68(668):e187-e196. doi:10.3399/bjgp18X694841

  28. Flynn KE, Lin L, Weinfurt KP. Sexual function and satisfaction among heterosexual and sexual minority U.S. adults: a cross-sectional survey. PLoS One. 2017;12(4):e0174981. doi:10.1371/journal.pone.0174981

  29. Moagi MM, van Der Wath AE, Jiyane PM, Rikhotso RS. Mental health challenges of lesbian, gay, bisexual and transgender people: an integrated literature review. Health SA. 2021;26:1487. doi:10.4102/hsag.v26i0.1487

  30. Flentje A, Clark KD, Cicero E, et al. Minority stress, structural stigma, and physical health among sexual and gender minority individuals: examining the relative strength of the relationships. Ann Behav Med. 2022;56(6):573-591. doi:10.1093/abm/kaab051

  31. Lavorgna L, Moccia M, Russo A, et al. Healthcare disparities stemming from sexual orientation of Italian patients with multiple sclerosis: a cross-sectional web-based study. Mult Scler Relat Disord. 2017;13:28-32. doi:10.1016/j.msard.2017.02.001

  32. Khayambashi S, Salter A, Tyry T, Cutter GR, Fox RJ, Marrie RA. Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with multiple sclerosis. Mult Scler Relat Disord. 2020;37:101440. doi:10.1016/j.msard.2019.101440

  33. Anderson A, Dierkhising J, Rush G, Carleton M, Rosendale N, Bove R. Experiences of sexual and gender minority people living with multiple sclerosis in Northern California: an exploratory study. Mult Scler Relat Disord. 2021;55:103214. doi:10.1016/j.msard.2021.103214

  34. Everett BG, Higgins JA, Haider S, Carpenter E. Do sexual minorities receive appropriate sexual and reproductive health care and counseling? J Womens Health (Larchmt). 2019;28(1):53-62. doi:10.1089/jwh.2017.6866

  35. Rosendale N, Ostendorf T, Evans DA, et al. American Academy of Neurology members’ preparedness to treat sexual and gender minorities. Neurology. 2019;93(4):159-166. doi:10.1212/WNL.0000000000007829

  36. Rosendale N, Wong JO, Flatt JD, Whitaker E. Sexual and gender minority health in neurology: a scoping review. JAMA Neurol. 2021;78(6):747-754. doi:10.1001/jamaneurol.2020.5536

  37. Haider A, Schneider E, Schuur J, et al. Comparing ways to ask patients about sexual orientation and gender identity in the emergency roomthe EQUALITY study. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); July 2019. doi:10.25302/7.2019.AD.110114IC

  38. Behn M, Kielhofner J, Panicker JN, Kaplan TB. Sexual dysfunction and commonly used drugs in neurology. Pract Neurol. 2024;24(3):207-214. doi:10.1136/pn-2023-003760

  39. Cavanaugh T. Sexual health history: talking sex with gender non-conforming and trans patients. Fenway Health. Accessed October 24, 2024. https:
    //fenwayhealth.org/wp-content/uploads/Taking-a-Sexual-Health-History
    -Cavanaugh-1.pdf

  40. DeNoble AE, Hall KS, Xu X, Zochowski MK, Piehl K, Dalton VK. Receipt of prescription contraception by commercially insured women with chronic medical conditions. Obstet Gynecol. 2014;123(6):1213-1220. doi:10.1097
    /AOG.0000000000000279

  41. Agénor M, Pérez AE, Wilhoit A, et al. Contraceptive care disparities among sexual orientation identity and racial/ethnic subgroups of U.S. women: a national probability sample study. J Womens Health (Larchmt). 2021;30(10):1406-1415. doi:10.1089/jwh.2020.8992

  42. Pol-Patil J, Glanz B, Safar L, et al. MeTooMS: sexual, physical, and emotional abuse experience among women with multiple sclerosis. Mult Scler. 2023;29(2):287-294. doi:10.1177/13524585221122169

  43. O’Leary M, Lammers S, Mageras A, Boyd M, Constantino R, Heyman R. Relationship between domestic violence and multiple sclerosis. Int J MS Care. 2008;10(2):27-32. doi:10.7224/1537-2073-10.2.27

  44. Brown TNT, Herman JL. Intimate partner violence and sexual abuse among LGBT people: a review of existing research. University of California Los Angeles. November 2015. https://williamsinstitute.law.ucla.edu/publications /ipv-sex-abuse-lgbt-people/

  45. Kaplan TB, Feldman T, Healey B, Behn M, Glanz B, Chitnis T. Sexual problems in MS: sex differences and their impact on quality of life. Mult Scler Relat Disord. 2023;74:104672. doi:10.1016/j.msard.2023.104672

  46. Bhatia S, Pappo AS, Acquazzino M, et al. Adolescent and young adult (AYA) oncology, version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(8):851-880. doi:10.6004/jnccn.2023.0040

Related Videos